A*STAR Singapore Immunology Network (A*STAR SIgN)
Is it safe to breastfeed after the COVID-19 vaccine?
8 Mar 2022Research reveals the safety of mRNA COVID-19 vaccines for breastfeeding mothers and the potential of passing immune protection to the baby.
Tanzania’s feverish five revealed
21 Jan 2022During the 2018 outbreak in Southeastern Tanzania, there were four dengue virus serotypes and the chikungunya virus in circulation, say A*STAR researchers.
Deciphering asthma’s genetic puzzle
14 Jan 2022A new link between gene variations in immune cells and allergic reactions explains why some individuals are more prone to developing asthma.
Fortifying T cells that fight liver cancer
14 Dec 2021Researchers engineer specialized T cells that can transiently and effectively attack liver cancer cells even in the presence of immunosuppressive drugs.
When allergies pass from mother to child
8 Dec 2021Maternal antibodies can cross the placenta and pass on mother’s allergies to her children in the womb.
Three decades of driving dedicated research
7 Dec 2021Through the years, A*STAR has always stood at the forefront of science and technology and innovation. Here’s how A*STAR came to be and what it has in store in the upcoming decades.
COVID-19’s far-reaching effects from lung to liver
30 Nov 2021Using single-cell sequencing technology, A*STAR scientists have identified a rare population of liver cells susceptible to damage from SARS-CoV-2 infections.
Immune secrets of the symptom-free
26 Nov 2021Unique immune responses shield some COVID-19 patients from the disease’s worst effects.
Flipping the switch on gut inflammation
26 Oct 2021A newly-discovered role for an immune regulator in T cells may help unravel the molecular basis of inflammatory bowel disease and serve as a promising therapeutic target.
SARS-CoV-2 antibodies hold out against variants
4 Oct 2021Data shows that antibodies produced as part of the COVID-19 immune response can neutralize a more transmissible variant of SARS-CoV-2.
Not all antibodies are created equal
10 Sep 2021Some neutralizing antibodies against SARS-CoV-2 may heighten lung tissue damage from COVID-19, an A*STAR study finds.
Memories of our first microbial encounters
8 Sep 2021Live bacterial strains present in fetal tissues may help lay the cornerstones of early and potentially life-long immunity.